Name
Purdue University Globle
NU569 FNP I Clinical – Lifespan Health Focus
Prof. Name
Date
New vaginal discharge, unexpected spotting, and lower abdominal cramping in a patient with a Kyleena intrauterine device (IUD) warrant clinical evaluation, particularly when these symptoms appear after a prolonged period without menstrual bleeding. Although hormonal IUDs can alter bleeding patterns, new or persistent pelvic symptoms may also be associated with infection, pregnancy, IUD malposition, cervical or uterine abnormalities, or other gynecologic conditions. A thorough history, physical examination, pregnancy testing, infection screening, and imaging when clinically indicated can help identify the underlying cause.
This NU569 SOAP Note examines the patient’s symptoms, medical history, review of systems, physical examination findings, differential diagnosis, and recommended diagnostic evaluation.
The female patient presented with abnormal vaginal discharge, intermittent vaginal spotting, and lower abdominal cramping. She reported experiencing lower abdominal cramps for approximately three days and spotting once daily for six consecutive days.
The patient has used a Kyleena hormonal IUD since 2019. Following IUD insertion, she experienced amenorrhea and had not had regular menstrual bleeding for several years. Her previous contraceptive method was oral contraceptive pills, which makes her baseline menstrual pattern difficult to establish.
She described the vaginal discharge as stringy and similar in appearance to old blood. She also reported intermittent episodes of clear or milky mucus-like discharge. In addition, she experienced occasional lower back discomfort.
The patient reported that her most recent sexual encounter occurred on a recent Friday with the same sexual partner she had maintained since her sexually transmitted infection (STI) screening in 2019.
The relevant gynecologic history includes:
Last menstrual period: Unknown
Previous contraception: Oral contraceptive pills
Current contraception: Kyleena IUD
Kyleena insertion: 2019
Menstrual pattern after IUD placement: Amenorrhea
The patient reported no known drug allergies (NKDA).
The patient reported no significant family medical history.
The patient’s surgical history includes a tonsillectomy in 1996.
The patient denied alcohol, tobacco, and recreational drug use.
Current medications include:
Fluoxetine (Prozac) 10 mg orally once daily
Kyleena IUD
The patient denied fever, chills, fatigue, appetite changes, and changes in activity level.
She denied chest pain, palpitations, and chest tightness.
She denied cough, wheezing, and shortness of breath.
The patient denied nausea, vomiting, diarrhea, constipation, and heartburn.
Positive genitourinary findings included:
Abnormal vaginal discharge
Intermittent vaginal spotting
Lower abdominal or pelvic discomfort
She denied urinary frequency, urinary urgency, hematuria, and dyspareunia.
The patient reported intermittent lower back pain.
The patient’s vital signs were stable:
Blood pressure: 118/57 mmHg
Heart rate: 68 beats/minute
Respiratory rate: 16 breaths/minute
Temperature: 37.1°C
Oxygen saturation: 100% on room air
Height: 5 feet 4 inches
Weight: 125 pounds
The patient appeared alert, well, and in no acute distress during the examination.
Cardiovascular examination revealed a regular rate and rhythm with normal S1 and S2 heart sounds. No murmurs were appreciated.
New pelvic symptoms in a patient using a hormonal IUD should be evaluated rather than automatically attributed to contraception. The timing of the symptoms is important because the patient had been amenorrheic for several years before developing new spotting, discharge, and cramping.
Several conditions may explain this clinical presentation.
Hormonal IUDs can cause changes in menstrual bleeding, particularly during the initial months following insertion. However, new bleeding or pelvic discomfort after years of stable use may warrant evaluation for IUD malposition, partial expulsion, or another gynecologic cause.
A pelvic examination can help determine whether the IUD strings are visible and whether there are signs of expulsion or cervical abnormalities. Ultrasound may be appropriate when the position of the IUD is uncertain or when pelvic pain persists.
Abnormal vaginal discharge combined with spotting and pelvic discomfort can occur with vaginal, cervical, or sexually transmitted infections. Although the patient reports the same sexual partner since her previous STI screening, this history does not completely exclude infection.
Testing should therefore be based on the patient’s current symptoms, sexual history, examination findings, and clinical risk factors.
Pelvic inflammatory disease (PID) should be considered when pelvic or lower abdominal pain occurs with abnormal vaginal or cervical findings. Depending on the examination, additional symptoms may include cervical motion tenderness, uterine tenderness, or adnexal tenderness.
The absence of fever or systemic symptoms does not by itself exclude a localized pelvic infection.
Pregnancy testing is an important component of evaluating new pelvic pain and abnormal bleeding in a reproductive-age patient, even when an IUD is being used.
Although IUDs are highly effective contraceptive methods, pregnancy can still occur rarely. If pregnancy occurs with an IUD in place, ectopic pregnancy must be considered because of its potential severity.
Urgent evaluation is appropriate when pelvic or abdominal pain is accompanied by pregnancy, particularly when symptoms include significant bleeding, dizziness, fainting, or severe or one-sided abdominal pain.
Persistent or unexplained abnormal bleeding may also be associated with cervical or endometrial abnormalities. The patient’s age, screening history, examination findings, pregnancy status, and risk factors should guide additional evaluation.
A focused diagnostic workup should be based on the patient’s history and examination findings.
A urine or serum pregnancy test should be considered early in the evaluation of reproductive-age patients with new pelvic pain or abnormal bleeding.
A positive pregnancy test in the setting of pelvic pain requires prompt assessment to determine the location and viability of the pregnancy and to exclude ectopic pregnancy.
A pelvic examination can provide important information about:
Vaginal discharge characteristics
Cervical inflammation or bleeding
IUD strings and possible expulsion
Cervical motion tenderness
Uterine tenderness
Adnexal tenderness or masses
The findings can help determine whether additional laboratory testing or imaging is necessary.
Depending on the clinical presentation, testing may include nucleic acid amplification testing (NAAT) for relevant sexually transmitted infections as well as testing for common causes of vaginitis.
Vaginal discharge should be evaluated based on its appearance, odor, associated symptoms, and examination findings rather than assuming that it represents a normal consequence of IUD use.
Urinalysis may be useful when urinary symptoms are present or when the clinical presentation creates concern for a urinary tract condition that could contribute to pelvic or lower abdominal discomfort.
Pelvic ultrasound may be appropriate when there is concern about IUD position, persistent pelvic pain, pregnancy-related complications, or another structural gynecologic condition.
Ultrasound can help evaluate the location of the IUD and identify findings that may require additional gynecologic assessment.
This case demonstrates why new vaginal spotting, abnormal discharge, and pelvic cramping should be assessed in a patient with a long-term hormonal IUD. Although hormonal contraception can influence bleeding patterns, symptoms that develop after years of stable use should not automatically be attributed to the IUD.
The clinical assessment should consider infectious, pregnancy-related, structural, cervical, uterine, and IUD-related causes. A patient’s sexual history, contraceptive history, previous screening, symptom duration, vital signs, and physical examination findings all contribute to the differential diagnosis.
The absence of fever or systemic illness is reassuring but does not eliminate the possibility of a localized gynecologic infection or another underlying condition.
Patients with pelvic pain, abnormal bleeding, or unusual vaginal discharge should seek prompt medical evaluation when symptoms are severe, worsening, or accompanied by concerning findings.
Red-flag symptoms include:
Severe or rapidly worsening abdominal or pelvic pain
Heavy vaginal bleeding
Fever or chills
Fainting or significant dizziness
Shoulder pain associated with possible pregnancy
Severe one-sided pelvic or abdominal pain
A positive pregnancy test with pelvic pain or bleeding
These symptoms can indicate conditions requiring urgent assessment, including ectopic pregnancy, significant infection, or other acute gynecologic problems.
The patient’s new vaginal discharge, intermittent spotting, lower abdominal cramping, and lower back discomfort require assessment despite her long-term use of a Kyleena IUD. The differential diagnosis includes IUD-related bleeding or malposition, vaginal or cervical infection, pelvic inflammatory disease, pregnancy, ectopic pregnancy, and other gynecologic abnormalities.
The initial evaluation should generally include a detailed history and physical examination, pregnancy testing, appropriate STI and vaginal infection testing, and assessment of IUD position when indicated. Pelvic ultrasound may be particularly useful when IUD malposition or a pregnancy-related complication is suspected.
The key clinical principle is that new pelvic symptoms after a prolonged period of stable hormonal IUD use should be evaluated rather than assumed to be a normal contraceptive side effect.
American College of Obstetricians and Gynecologists. (n.d.). Long-acting reversible contraception (LARC): Intrauterine device (IUD) and implant. https://www.acog.org/womens-health/faqs/long-acting-reversible-contraception-iud-and-implant
Centers for Disease Control and Prevention. (2021). Sexually transmitted infections treatment guidelines, 2021. U.S. Department of Health and Human Services. https://www.cdc.gov/std/treatment-guidelines/default.htm
Cleveland Clinic. (n.d.). Vaginal discharge: Causes, colors, and treatment. https://my.clevelandclinic.org/health/symptoms/4719-vaginal-discharge
Merck Manual Professional Edition. (n.d.). Pelvic pain in women. https://www.merckmanuals.com/professional/gynecology-and-obstetrics
Mayo Clinic. (n.d.). Hormonal IUD. https://www.mayoclinic.org/tests-procedures/hormonal-iud/about/pac-20394784
